Polony Sequencing and the $1000 Genome

Polony 测序和价值 1000 美元的基因组

基本信息

项目摘要

DESCRIPTION (provided by applicant): We propose to further develop and utilize ultra-high throughput polony genome sequencing with the primary goal of generating raw data to re-sequence the human genome in about one week (including library prep and sequencing) for less than $1,000. Currently, the technology is well advanced, but further progress is needed to meet our goals. As the critical quantitative milestone of the project, we will report the sequence for a human genome with "a target sequence quality equivalent to or better than that of the mouse assembly published in December 2002 (Nature 420:520, 2002)". The project is divided into four specific aims, which are to (1) increase the polony sequencing read length using a cyclic ligation strategy that involves enzymatic cleavage, (2) improve the library construction and emulsion protocols, (3) increase read density by moving to alternative clonal amplification strategies (other than emulsion PCR or ePCR), and (4) extend our software capabilities to allow SNP calls from our new proposed sequencing raw data. Progress towards our goals is at an advanced stage. We are able to routinely sequence bacterial genomes and we are on the verge of sequencing an entire human genome to the required quality level. Overall, we feel that there are substantial rewards to be gained by pursuing the goals described herein. We have extensive experience with the proposed technologies and we have a clear path toward the $1,000 genome. PUBLIC HEALTH RELEVANCE: Herein we propose to further develop and utilize Polony Sequencing Technology with the primary goal of sequencing the human genome in about one week at a cost of less than $1,000. We propose several approaches that will progressively move us toward and beyond the $1,000 human genome. We firmly believe that polony sequencing technology, as proposed, can achieve the $1,000 genome goal and undoubtedly revolutionize medicine.
描述(由申请人提供):我们建议进一步开发和利用超高通量聚合酶克隆基因组测序,主要目标是在大约一周内(包括文库制备和测序)生成原始数据以重新测序人类基因组,费用低于1,000美元。 目前,这项技术已经非常先进,但还需要进一步的进步才能实现我们的目标。 作为该项目的关键定量里程碑,我们将报告人类基因组的序列,其“靶序列质量等于或优于2002年12月发表的小鼠组装体的靶序列质量(Nature 420:520,2002)”。 该项目分为四个具体目标,即(1)使用涉及酶切的循环连接策略增加polony测序读段长度,(2)改进文库构建和乳化方案,(3)通过移动到替代克隆扩增策略来增加读段密度(除了乳液PCR或ePCR),和(4)扩展我们的软件能力以允许来自我们新提出的测序原始数据的SNP调用。 实现我们目标的进展已进入后期阶段。 我们能够对细菌基因组进行常规测序,我们即将对整个人类基因组进行测序,达到所需的质量水平。 总的来说,我们认为,通过追求本文所述的目标,可以获得大量回报。 我们在拟议的技术方面拥有丰富的经验,我们有一条通往1,000美元基因组的明确道路。 公共卫生相关性:在此,我们建议进一步开发和利用Polony测序技术,其主要目标是在大约一周内以低于1000美元的成本对人类基因组进行测序。 我们提出了几种方法,将逐步推动我们走向和超越1,000美元的人类基因组。 我们坚信,正如所提出的那样,polony测序技术可以实现1,000美元的基因组目标,无疑会彻底改变医学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(5)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeremy S Edwards其他文献

Jeremy S Edwards的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeremy S Edwards', 18)}}的其他基金

Knowledge Management Center for Illuminating the Druggable Genome
阐明可药物基因组的知识管理中心
  • 批准号:
    10598542
  • 财政年份:
    2018
  • 资助金额:
    $ 104.78万
  • 项目类别:
Haplotype Resolved Sequencing Technology
单倍型解析测序技术
  • 批准号:
    8728983
  • 财政年份:
    2013
  • 资助金额:
    $ 104.78万
  • 项目类别:
Haplotype Resolved Sequencing Technology
单倍型解析测序技术
  • 批准号:
    8568163
  • 财政年份:
    2013
  • 资助金额:
    $ 104.78万
  • 项目类别:
A Spatially coarse-grained, rule-based frame work for modeling large molecular
用于建模大分子的空间粗粒度、基于规则的框架
  • 批准号:
    8446651
  • 财政年份:
    2012
  • 资助金额:
    $ 104.78万
  • 项目类别:
A Spatially coarse-grained, rule-based frame work for modeling large molecular
用于建模大分子的空间粗粒度、基于规则的框架
  • 批准号:
    8503615
  • 财政年份:
    2012
  • 资助金额:
    $ 104.78万
  • 项目类别:
A Spatially coarse-grained, rule-based frame work for modeling large molecular
用于建模大分子的空间粗粒度、基于规则的框架
  • 批准号:
    8892207
  • 财政年份:
    2012
  • 资助金额:
    $ 104.78万
  • 项目类别:
A Spatially coarse-grained, rule-based frame work for modeling large molecular
用于建模大分子的空间粗粒度、基于规则的框架
  • 批准号:
    8656139
  • 财政年份:
    2012
  • 资助金额:
    $ 104.78万
  • 项目类别:
Polony Sequencing and the $1000 Genome
Polony 测序和价值 1000 美元的基因组
  • 批准号:
    8324730
  • 财政年份:
    2010
  • 资助金额:
    $ 104.78万
  • 项目类别:
Polony Sequencing and the $1000 Genome
Polony 测序和价值 1000 美元的基因组
  • 批准号:
    8134450
  • 财政年份:
    2010
  • 资助金额:
    $ 104.78万
  • 项目类别:
UNM MODELING
新墨西哥大学建模
  • 批准号:
    7905561
  • 财政年份:
    2009
  • 资助金额:
    $ 104.78万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 104.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 104.78万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 104.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 104.78万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 104.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 104.78万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 104.78万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 104.78万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 104.78万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 104.78万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了